Jennison Associates’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Jennison Associates’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-683,451	Closed	-$9.66M	–	690
2016 Q2	$9.66M	Sell	683,451 -989	-0.1%	-$15.4K	0.01%	468
2016 Q1	$9.57M	Buy	684,440 +6,830	+1%	+$100K	0.01%	463
2015 Q4	$13.8M	Buy	677,610 +3,248	+0.5%	+$50.1K	0.01%	460
2015 Q3	$8.86M	Sell	674,362 -367,461	-35%	-$6.1M	0.01%	516
2015 Q2	$16M	Buy	1,041,823 +6,601	+0.6%	+$127K	0.01%	482
2015 Q1	$20.7M	Sell	1,035,222 -44,995	-4%	-$1.01M	0.02%	435
2014 Q4	$22.7M	Sell	1,080,217 -4,303	-0.4%	-$87.6K	0.02%	427
2014 Q3	$20.2M	Buy	1,084,520 +375,513	+53%	+$6.8M	0.02%	435
2014 Q2	$16.4M	Buy	+709,007	New	+$12.5M	0.02%	446

Other funds holding AGTC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates's AGTC Position: Q3 2016 in Review

Jennison Associates sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2016, closing a stake of 683,451 shares — an estimated $9.66M sold.

Jennison Associates first reported a position in AGTC in Q2 2014 and held it in 9 quarters. The position peaked at $22.7M in Q4 2014. 95 funds tracked by Wall St. Rank hold AGTC as of Q3 2016.

Jennison Associates reported no remaining Applied Genetic Technologies Corporation position as of Q3 2016 after selling out during the quarter.
Jennison Associates sold 683,451 Applied Genetic Technologies Corporation shares in Q3 2016, an estimated $9.66M.
Jennison Associates first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 9 quarters.
Jennison Associates's Applied Genetic Technologies Corporation position peaked at $22.7M in Q4 2014.
95 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2016.

Based on Jennison Associates's 13F filing for Q3 2016, filed 1 Nov 2016.